Holen Sie sich die Stockscreener-App
27.23
1.04%
0.28
Handel nachbörslich:
27.35
0.12
+0.44%
Schlusskurs vom Vortag:
$26.95
Offen:
$25.16
24-Stunden-Volumen:
18.46M
Relative Volume:
0.80
Marktkapitalisierung:
$6.29B
Einnahmen:
$1.24B
Nettoeinkommen (Verlust:
$101.26M
KGV:
61.89
EPS:
0.44
Netto-Cashflow:
$149.62M
1W Leistung:
+1.57%
1M Leistung:
-21.50%
6M Leistung:
+26.30%
1J Leistung:
+119.42%
1-Tages-Spanne:
$25.16
$27.44
1-Wochen-Bereich:
$25.16
$29.84
52-Wochen-Spanne:
$11.20
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Firmenname
Hims Hers Health Inc
Sektor
Telefon
415-851-0195
Adresse
2269 CHESTNUT ST, SAN FRANCISCO
Vergleichen Sie HIMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
27.23 | 6.29B | 1.24B | 101.26M | 149.62M | 0.44 |
|
PG
Procter Gamble Co
|
170.63 | 396.58B | 84.35B | 15.48B | 15.47B | 6.28 |
|
UL
Unilever Plc Adr
|
63.84 | 152.89B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
95.50 | 77.04B | 20.10B | 2.89B | 3.55B | 3.52 |
|
KMB
Kimberly Clark Corp
|
142.81 | 47.28B | 20.06B | 2.55B | 2.51B | 7.55 |
|
KVUE
Kenvue Inc
|
23.39 | 43.57B | 15.46B | 1.03B | 1.34B | 0.53 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-01-07 | Eingeleitet | BTIG Research | Buy |
| 2024-12-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-08-22 | Eingeleitet | Needham | Buy |
| 2024-08-09 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-04-16 | Herabstufung | Jefferies | Buy → Hold |
| 2024-04-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-02-28 | Hochstufung | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | Imperial Capital | In-line |
| 2023-07-28 | Eingeleitet | TD Cowen | Outperform |
| 2023-04-11 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-02-09 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-08 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-07-15 | Eingeleitet | SVB Leerink | Underperform |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-10 | Eingeleitet | Deutsche Bank | Hold |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-11-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Eingeleitet | BofA Securities | Neutral |
| 2021-05-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Eingeleitet | Truist | Hold |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-03-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Eingeleitet | Citigroup | Neutral |
| 2021-02-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-02-08 | Eingeleitet | Tigress Financial | Buy |
Alle ansehen
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Hims & Hers Health, Inc. (HIMS) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers - The Globe and Mail
Why Hims & Hers Health, Inc. (HIMS) Declined on Wednesday - MSN
HIMS Stock: Ready To Bounce Back From $30? - Nasdaq
Long Term Trading Analysis for (HIMS) - news.stocktradersdaily.com
BofA maintains Hims & Hers stock underperform with $22 target - Investing.com
BofA maintains Hims & Hers stock underperform with $22 target By Investing.com - Investing.com UK
Hims & Hers health CFO sells $330,081 in stock By Investing.com - Investing.com India
Hims & Hers health chief legal officer sells $280,314 in stock - Investing.com Australia
Hims & Hers health CFO sells $330,081 in stock - Investing.com
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Insider Monkey
Robinhood, AppLovin, Hims & Hers Health, Sleep Number, and Covenant Logistics Shares Plummet, What You Need To Know - Yahoo Finance
Robinhood, AppLovin, Hims & Hers Health, Sleep Number, and Covenant Logistics Shares Plummet, What You Need To Know | FinancialContent - FinancialContent
Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it - Yahoo Finance
BofA keeps Hims & Hers stock at underperform, target at $22 By Investing.com - Investing.com India
Lobbying Update: $60,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed - Nasdaq
Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025 - The Joplin Globe
Is Hims Stock a Buy, Sell, or Hold? - theafricalogistics.com
8,601 Shares in Hims & Hers Health, Inc. (NYSE:HIMS) Bought by O Shaughnessy Asset Management LLC - Defense World
InvestingPro’s Fair Value model predicted HIMS stock’s dramatic correction By Investing.com - Investing.com Canada
Truist Financial Has Lowered Expectations for Hims & Hers Health (NYSE:HIMS) Stock Price - Defense World
Why Hims & Hers Stock Just Collapsed - AOL.com
Hims & Hers Health, Inc. (HIMS) Rises But Trails Market: What Investors Should Know - Yahoo
Jefferies raises Hims & Hers stock target to $25, maintains hold - Investing.com Canada
Hims & Hers, at a crossroads, wants to be the Netflix of healthcare - Sherwood News
Hims & Hers health COO Melissa Baird sells $910,687 in stock - Investing.com Canada
Here’s Cedar Grove Capital Management’s Take Away from Its Short Position Hims and Hers Health (HIMS) - MSN
Here’s Cedar Grove Capital Management’s Takeaway from Its Short Position Hims and Hers Health (HIMS) - Insider Monkey
Hims’ Weight Loss Expansion: Real Growth or Just Hype? - MarketBeat
Truist Cuts Price Target on Hims & Hers Health to $33 From $39, Keeps Hold Rating - MarketScreener
PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know - Yahoo Finance
Here’s Why Hims & Hers Health (HIMS) is Growing Revenue And Profitability - Insider Monkey
Market Update: Trident Digital Tech Holdings, Tesla, Hims & Hers Health, and SoFi Technologies Experience Notable Market Activity - Insider Monkey
Sei Investments Co. Reduces Stock Position in Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - MSN
Hims & Hers health executive sells $63,402 in stock By Investing.com - Investing.com India
Hims & Hers health PAO Becklund Irene sells shares worth $63,402 - Investing.com Canada
Hims & Hers health executive sells $63,402 in stock - Investing.com
Hims & Hers CFO Okupe Oluyemi sells $338,833 in stock - Investing.com
Hims & Hers Health (NYSE:HIMS) Rises 5% Over Last Quarter Following Strong 2024 Earnings - Yahoo Finance
Hims & Hers : Telehealth's billion-dollar surge - MarketScreener
Zepbound Now Available Through Hims & Hers - Endocrinology Advisor
‘Hold the Phone,’ Says Morgan Stanley on Hims & Hers Health Stock (HIMS) - markets.businessinsider.com
Eli Lilly Vs. Hims & Hers In DTC Weight Loss Market?There Is Only One Winner (NYSE:LLY) - Seeking Alpha
Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):